GC Medical Science Corporation (KOSDAQ:142280)

South Korea · Delayed Price · Currency is KRW

3,000.00

+10.00 (0.33%)

At close: Jul 1, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Green Cross MS Co., Ltd.	109.12B	104.60B	94.07B	110.82B	100.83B
Green Cross MS Co., Ltd. Growth	4.32%	11.20%	-15.12%	9.91%	-9.16%
Green Cross Medis Co., Ltd.	15.83B	13.16B	11.76B	14.88B	12.79B
Green Cross Medis Co., Ltd. Growth	20.28%	11.97%	-21.02%	16.38%	-0.62%
Consolidated Adjustments	-16.54B	-13.91B	-11.81B	-12.60B	-11.94B
Total	108.41B	103.85B	94.01B	113.11B	101.67B
Total Growth	4.39%	10.47%	-16.88%	11.25%	-10.32%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	99.67B	96.05B	87.99B	101.11B	85.11B
South Korea Growth	3.77%	9.16%	-12.98%	18.80%	-3.53%
Overseas	8.74B	7.80B	6.02B	12.00B	16.56B
Overseas Growth	12.08%	29.60%	-49.83%	-27.57%	-34.16%
Total	108.41B	103.85B	94.01B	113.11B	101.67B
Total Growth	4.39%	10.47%	-16.88%	11.25%	-10.32%